|« Previous month||Next month »|
30-Jun-2009 - US raw materials supplier Originates has boosted its pharmaceutical bovine hide gelatin manufacturing capacity with the addition of two new ISO 9000/9001 certified, GMP-standard production facilities in South America.
30-Jun-2009 - Rising demand in China has led to Toray Fine Chemicals (TFC) establishing a joint venture to produce dimethylsulfoxide (DMSO), a reaction solvent in pharma production.
30-Jun-2009 - Mylan has followed Teva’s lead by partnering to develop follow-on biologics (FOB), with the Indian generic maker regarding Biocon as the “ideal partner” to help it enter the market. ...
29-Jun-2009 - US Marshals have seized products from Caraco’s facilities in Michigan because of concerns over cGMP compliance, which has led to Sun Pharma withdrawing its financial guidance.
29-Jun-2009 - Researchers have used nanoparticles to stabilise membrane proteins, allowing for detailed analysis of their structure and molecular functions that could help drug discovery.
25-Jun-2009 - Dutch biopharmaceuticals producer OctoPlus has begun manufacturing operations at its new facility in Leiden, the Netherlands.
25-Jun-2009 - KV Pharmaceutical found deficiencies and instances of noncompliance during its internal investigation, which was launched in response to issues with the FDA and allegations of management misconduct.
25-Jun-2009 - in-PharmaTechnologist presents its latest round up of appointments in the pharmaceutical sector, including Lilly’s CEO taking a role at Nike and Takeda’s illustrious global advisory board.
25-Jun-2009 - Sanyo Biomedical and Environmental Solutions claims the H202 steralisation approach used by its Steisonic CxP MCO-19AIC(UVH) cell incubator system is an industry first and effective replacement for ethylene oxide (EtO)....
24-Jun-2009 - Belgian drug and chemicals giant Solvay has lost out on a contract to supply the Dutch government with an H1N1 vaccine after it said it could not meet the production...
24-Jun-2009 - US contractor Azopharma has added new GMP quality cytotoxics and high-potency manufacturing capacity at its facility in Hollywood, South Florida in a bid to strengthen its position in the trial...
24-Jun-2009 - The world pharma packaging market is predicted to rise 5.3 per cent to more than $47bn (€33.3bn) in 2013, with increased use of biologics driving change.
24-Jun-2009 - Regulatory agencies are putting increased emphasis on transparency, with the FDA holding its first public meeting on the topic and the EMEA seeking feedback from citizens on its draft policy.
23-Jun-2009 - Swiss drugmaker Helsinn has unveiled plans to add high-potency API R&D and manufacturing capacity to its facility in Biasca in the south of the country.
23-Jun-2009 - Sigpack Systems, a subsidiary of Bosch Packaging Technology, claims its new toploader unit will both improve the efficiency and cut the cost of handling delicate pharmaceutical packaging.
23-Jun-2009 - Emisphere has entered into a research agreement with Syracuse University, which will combine their respective oral drug delivery technologies to enhance absorption of an appetite-suppressing hormone.
22-Jun-2009 - The growth of the Chinese vaccine market is set to outstrip the country’s pharma sector, according to a Frost & Sullivan (F&S) report that predicts 14-15 per cent CAGR. ...
22-Jun-2009 - Millipore has ramped up capacity for its Mobius range of single use bio-processing and manufacturing technologies with a new purpose built production facility in Danvers, Massachusetts.
22-Jun-2009 - The number of pharma employees in New Jersey, US fell by 1,400 in 2008, with R&D expenditure, capital investment and product trials also declining, according to a report.
18-Jun-2009 - Seven of the top ten drugs will be biopharmaceuticals by 2014 according to sector analysts Evaluate Pharma.
18-Jun-2009 - German aseptic filling specialist Vetter has boosted packaging operations at its new facility in Ravensburg to meet growing demand for cost-effective secondary packaging services
18-Jun-2009 - Automation expenditures in pharma manufacturing are predicted to reach $3bn (€2.15bn) by 2012 because companies must invest in the current “adapt or die” environment, according to a report.
18-Jun-2009 - Watson Pharmaceuticals is to acquire Arrow Group for $1.75bn (€1.26bn), adding to the company’s manufacturing network and providing it with the expertise needed to enter the biogenerics market.
17-Jun-2009 - As rumours of a failed Sanofi Aventis’ bid for a US rival circulate, F&S’ analysis of M&As is well timed, even if its conclusions will be difficult reading for a...
17-Jun-2009 - Large pharma companies will increase the level of supply chain activities they outsource in the next few years but smaller businesses are predicted to keep them in-house, according to a...
|« Previous month||Next month »|